{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:45:55Z","timestamp":1793724355101,"version":"4.6.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11738-6","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:52:52Z","timestamp":1774954372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decoding ferroptosis and apoptosis crosstalk in glioblastoma: molecular mechanisms, microenvironmental regulation, and therapeutic advances"],"prefix":"10.1007","volume":"53","author":[{"given":"Abdullah","family":"Alkhammash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghallab","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"7","key":"11738_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072116","volume":"15","author":"SSK Yalamarty","year":"2023","unstructured":"Yalamarty SSK et al (2023) Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM). Cancers 15(7):2116","journal-title":"Cancers"},{"issue":"1","key":"11738_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010351","volume":"22","author":"A Ou","year":"2020","unstructured":"Ou A, Yung WA, Majd NJIjoms (2020) Molecular mechanisms of treatment resistance in glioblastoma. Int J Mol Sci 22(1):351","journal-title":"Int J Mol Sci"},{"key":"11738_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1347877","volume":"15","author":"A Ballest\u00edn","year":"2024","unstructured":"Ballest\u00edn A et al (2024) Peritumoral brain zone in glioblastoma: Biological, clinical and mechanical features. Front Immunol 15:1347877","journal-title":"Front Immunol"},{"issue":"4","key":"11738_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1021\/jacsau.2c00681","volume":"3","author":"Q Do","year":"2023","unstructured":"Do Q et al (2023) Differential contributions of distinct free radical peroxidation mechanisms to the induction of ferroptosis. JACS Au 3(4):1100\u20131117","journal-title":"JACS Au"},{"key":"11738_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto G et al (2020) Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol 28:101328","journal-title":"Redox Biol"},{"key":"11738_CR6","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao JY, Dixon SJJC (2016) Mechanisms of ferroptosis. Cell Mol Life Sci 73:2195\u20132209","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"11738_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41420-025-02711-6","volume":"11","author":"H Sun","year":"2025","unstructured":"Sun H et al (2025) Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers. Cell Death Discov 11(1):407","journal-title":"Cell Death Discov"},{"issue":"1","key":"11738_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41420-025-02744-x","volume":"11","author":"S Singh","year":"2025","unstructured":"Singh S et al (2025) Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance. Cell Death Discov 11(1):448","journal-title":"Cell Death Discov"},{"issue":"1","key":"11738_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2019.151058","volume":"99","author":"H Wang","year":"2020","unstructured":"Wang H et al (2020) Mitochondria regulation in ferroptosis. Eur J Cell Biol 99(1):151058","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"11738_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y et al (2016) Ferroptosis: process and function. Cell Death Differ 23(3):369\u2013379","journal-title":"Cell Death Differ"},{"issue":"5","key":"11738_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-025-01638-2","volume":"40","author":"N Patil","year":"2025","unstructured":"Patil N, Bhatt LKJMBD (2025) Targeting Acyl-CoA synthetase long-chain family member 4: a potential approach for the treatment of cerebral ischemia\/reperfusion injury. Metab Brain Dis 40(5):1\u201322","journal-title":"Metab Brain Dis"},{"issue":"11","key":"11738_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112115","volume":"16","author":"J Korbecki","year":"2024","unstructured":"Korbecki J et al (2024) Phospholipid acyltransferases: characterization and involvement of the enzymes in metabolic and cancer diseases. Cancers 16(11):2115","journal-title":"Cancers"},{"issue":"10","key":"11738_CR13","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y et al (2023) GPX4 in cell death, autophagy, and disease. Autophagy 19(10):2621\u20132638","journal-title":"Autophagy"},{"issue":"4","key":"11738_CR14","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/jcp.29232","volume":"235","author":"X Zhang","year":"2020","unstructured":"Zhang X et al (2020) Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin. J Cell Physiol 235(4):3425\u20133437","journal-title":"J Cell Physiol"},{"issue":"1","key":"11738_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1034\/j.1600-065X.2003.00048.x","volume":"193","author":"EM Creagh","year":"2003","unstructured":"Creagh EM, Conroy H, Martin SJJIr (2003) Caspase\u2010activation pathways in apoptosis and immunity. Immunol Rev 193(1):10\u201321","journal-title":"Immunol Rev"},{"issue":"2","key":"11738_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.15171\/apb.2019.024","volume":"9","author":"RJApb Jan","year":"2019","unstructured":"Jan RJApb (2019) Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Advanced Pharmaceutical Bulletin 9(2):205","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"11","key":"11738_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/tox.22987","volume":"35","author":"RS Thakur","year":"2020","unstructured":"Thakur RS, Devaraj EJET (2020) Lagerstroemia speciosa (L.) Pers. triggers oxidative stress mediated apoptosis via intrinsic mitochondrial pathway in HepG2 cells. Environ Toxicol 35(11):1225\u20131233","journal-title":"Environ Toxicol"},{"issue":"5","key":"11738_CR18","doi-asserted-by":"publisher","first-page":"F983","DOI":"10.1152\/ajprenal.90579.2008","volume":"296","author":"M Jiang","year":"2009","unstructured":"Jiang M et al (2009) Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway. American J Physiology-Renal Physiology 296(5):F983\u2013F993","journal-title":"American J Physiology-Renal Physiology"},{"issue":"22","key":"11738_CR19","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1158\/1078-0432.CCR-15-0364","volume":"21","author":"CJ Gibson","year":"2015","unstructured":"Gibson CJ, Davids MSJCcr (2015) BCL-2 antagonism to target the intrinsic mitochondrial pathway of apoptosis. Clin Cancer Res 21(22):5021\u20135029","journal-title":"Clin Cancer Res"},{"key":"11738_CR20","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s12272-011-0817-5","volume":"34","author":"KH Kim","year":"2011","unstructured":"Kim KH et al (2011) Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Arch Pharmacal Res 34:1363\u20131372","journal-title":"Arch Pharmacal Res"},{"issue":"1","key":"11738_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01247-5","volume":"21","author":"Y-H Han","year":"2023","unstructured":"Han Y-H et al (2023) Regulation of anoikis by extrinsic death receptor pathways. Cell Commun Signal 21(1):227","journal-title":"Cell Commun Signal"},{"issue":"1","key":"11738_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/excr.2000.4839","volume":"256","author":"B Antonsson","year":"2000","unstructured":"Antonsson B, Martinou J-C (2000) The Bcl-2 protein family. Exp Cell Res 256(1):50\u201357","journal-title":"Exp Cell Res"},{"key":"11738_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216744","author":"G Wang","year":"2024","unstructured":"Wang G et al (2024) Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: emphasis on cell death mechanism crosstalk. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2024.216744","journal-title":"Cancer Lett"},{"issue":"1","key":"11738_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02328-9","volume":"11","author":"G Eskander","year":"2025","unstructured":"Eskander G et al (2025) Insights on the crosstalk among different cell death mechanisms. Cell Death Discov 11(1):56","journal-title":"Cell Death Discov"},{"issue":"1","key":"11738_CR25","first-page":"3400147","volume":"2023","author":"P Wu","year":"2023","unstructured":"Wu P et al (2023) Organelle\u2010specific mechanisms in crosstalk between apoptosis and ferroptosis. Oxid Med Cell Longev 2023(1):3400147","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"11738_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/life11040332","volume":"11","author":"V Brillo","year":"2021","unstructured":"Brillo V et al (2021) Mitochondrial dynamics, ROS, and cell signaling: a blended overview. Life Basel 11(4):332","journal-title":"Life Basel"},{"key":"11738_CR27","unstructured":"Le Bras M et al (2005) Reactive oxygen species and the mitochondrial signaling pathway of cell death."},{"issue":"3","key":"11738_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05716-0","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y et al (2023) The interaction between ferroptosis and inflammatory signaling pathways. Cell Death Dis 14(3):205","journal-title":"Cell Death Dis"},{"issue":"22","key":"11738_CR29","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang DJTFj (2022) Signaling pathways and defense mechanisms of ferroptosis. FEBS J 289(22):7038\u20137050","journal-title":"FEBS J"},{"key":"11738_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176820","volume":"979","author":"X Ren","year":"2024","unstructured":"Ren X et al (2024) Cerebroprotein hydrolysate-I ameliorates cognitive dysfunction in APP\/PS1 mice by inhibiting ferroptosis via the p53\/SAT1\/ALOX15 signalling pathway. Eur J Pharmacol 979:176820","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"11738_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.molmed.2016.05.002","volume":"22","author":"S Menegon","year":"2016","unstructured":"Menegon S, Columbano A, Giordano SJTimm (2016) The dual roles of NRF2 in cancer. Trends Mol Med 22(7):578\u2013593","journal-title":"Trends Mol Med"},{"key":"11738_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","author":"T Wu","year":"2021","unstructured":"Wu T et al (2021) clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The innovation. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"The innovation"},{"issue":"3","key":"11738_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102649","volume":"36","author":"S Mashayekhi","year":"2025","unstructured":"Mashayekhi S et al (2025) Ferroptosis as a therapeutic target in glioblastoma: mechanisms and emerging strategies. Mol Ther Nucleic Acids 36(3):102649","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"11738_CR34","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3390\/antiox11112123","volume":"11","author":"Y Luo","year":"2022","unstructured":"Luo Y et al (2022) Ferroptosis and its potential role in glioma: from molecular mechanisms to therapeutic opportunities. Antioxidants Basel 11(11):2123","journal-title":"Antioxidants Basel"},{"key":"11738_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1273841","author":"M Han","year":"2024","unstructured":"Han M et al (2024) Regulated cell death in glioma: promising targets for natural small-molecule compounds. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2024.1273841","journal-title":"Front Oncol"},{"issue":"2","key":"11738_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41419-024-06558-0","volume":"15","author":"X Li","year":"2024","unstructured":"Li X et al (2024) Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11. Cell Death Dis 15(2):168","journal-title":"Cell Death Dis"},{"issue":"12","key":"11738_CR37","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.7150\/ijbs.96476","volume":"20","author":"Y Wei","year":"2024","unstructured":"Wei Y et al (2024) Targeting ferroptosis opens new avenues in gliomas. Int J Biol Sci 20(12):4674","journal-title":"Int J Biol Sci"},{"key":"11738_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.917537","volume":"12","author":"M Lu","year":"2022","unstructured":"Lu M et al (2022) The molecular mechanisms of ferroptosis and its role in glioma progression and treatment. Front Oncol 12:917537","journal-title":"Front Oncol"},{"key":"11738_CR39","unstructured":"Bikfalvi A et al (2023)Challenges in glioblastoma research: focus on the tumor microenvironment. 9(1): p. 9-27"},{"issue":"3","key":"11738_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10030112","volume":"10","author":"H Rahimi Koshkaki","year":"2020","unstructured":"Rahimi Koshkaki H et al (2020) Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma. J Pers Med 10(3):112","journal-title":"J Pers Med"},{"issue":"5","key":"11738_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biology12050736","volume":"12","author":"E Agosti","year":"2023","unstructured":"Agosti E et al (2023) Tumor microenvironment and glioblastoma cell interplay as promoters of therapeutic resistance. Biology 12(5):736","journal-title":"Biology"},{"issue":"9","key":"11738_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092257","volume":"10","author":"M Dapash","year":"2021","unstructured":"Dapash M et al (2021) The interplay between glioblastoma and its microenvironment. Cells 10(9):2257","journal-title":"Cells"},{"issue":"11","key":"11738_CR43","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1007\/s12035-022-02996-z","volume":"59","author":"A Virtuoso","year":"2022","unstructured":"Virtuoso A et al (2022) Tumor microenvironment and immune escape in the time course of glioblastoma. Mol Neurobiol 59(11):6857\u20136873","journal-title":"Mol Neurobiol"},{"key":"11738_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.869307","volume":"13","author":"N Chen","year":"2022","unstructured":"Chen N, Peng C, Li DJFiI (2022) Epigenetic underpinnings of inflammation: a key to unlock the tumor microenvironment in glioblastoma. Front Immunol 13:869307","journal-title":"Front Immunol"},{"issue":"3","key":"11738_CR45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s12276-024-01180-8","volume":"56","author":"T Bae","year":"2024","unstructured":"Bae T et al (2024) Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer. Exp Mol Med 56(3):501\u2013514","journal-title":"Exp Mol Med"},{"issue":"1","key":"11738_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07646-5","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z et al (2025) USP9X integrates TGF-\u03b2 and hypoxia signalings to promote ovarian cancer chemoresistance via HIF-2\u03b1-maintained stemness. Cell Death Dis 16(1):312","journal-title":"Cell Death Dis"},{"issue":"8","key":"11738_CR47","volume":"25","author":"YK Choi","year":"2024","unstructured":"Choi YK (2024) Detrimental roles of hypoxia-inducible factor-1\u03b1 in severe hypoxic brain diseases. JIJoMS 25(8):4465","journal-title":"JIJoMS"},{"key":"11738_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156900","volume":"143","author":"X Zhang","year":"2025","unstructured":"Zhang X et al (2025) Protocatechuic acid suppresses ferroptosis to protect against hypoxic-ischemic encephalopathy by targeting the HIF-1\u03b1\/VEGFA axis. Phytomedicine 143:156900","journal-title":"Phytomedicine"},{"key":"11738_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01451-5","author":"G Pan","year":"2025","unstructured":"Pan G et al (2025) EZH2 suppresses IR-induced ferroptosis by forming a co-repressor complex with HIF-1\u03b1 to inhibit ACSL4: Targeting EZH2 enhances radiosensitivity in KDM6A-deficient esophageal squamous carcinoma. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-025-01451-5","journal-title":"Cell Death Differ"},{"issue":"4","key":"11738_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040510","volume":"15","author":"L Gong","year":"2025","unstructured":"Gong L et al (2025) Interactions between non-coding RNAs and HIF-1alpha in the context of colorectal cancer. Biomolecules 15(4):510","journal-title":"Biomolecules"},{"issue":"2","key":"11738_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/biom15020256","volume":"15","author":"S Yang","year":"2025","unstructured":"Yang S et al (2025) Hypoxia Regulates the Proliferation and Apoptosis of Coronary Artery Smooth Muscle Cells Through HIF-1\u03b1 Mediated Autophagy in Yak. Biomolecules 15(2):256","journal-title":"Biomolecules"},{"issue":"8","key":"11738_CR52","doi-asserted-by":"publisher","DOI":"10.7150\/jca.108582","volume":"16","author":"J Ran","year":"2025","unstructured":"Ran J et al (2025) Hypoxia regulates glycolysis through the HIF-1\u03b1\/BMAL1\/ALDOC axis to reduce oxaliplatin sensitivity in colorectal cancer. J Cancer 16(8):2503","journal-title":"J Cancer"},{"key":"11738_CR53","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2025.1002304","volume":"6","author":"A Di Spirito","year":"2025","unstructured":"Di Spirito A et al (2025) Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies. Exploration of Targeted Anti-tumor Therapy 6:1002304","journal-title":"Exploration of Targeted Anti-tumor Therapy"},{"key":"11738_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03360-3","volume":"22","author":"C Acioglu","year":"2025","unstructured":"Acioglu C, Elkabes SJJoN (2025) Innate immune sensors and regulators at the blood brain barrier: focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation. J Neuroinflammation 22:39","journal-title":"J Neuroinflammation"},{"issue":"1","key":"11738_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-025-03377-9","volume":"44","author":"Y Yang","year":"2025","unstructured":"Yang Y et al (2025) Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy. J Exp Clin Cancer Res 44(1):1\u201328","journal-title":"J Exp Clin Cancer Res"},{"key":"11738_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1586806","volume":"16","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zhao BJFiI (2025) The role of tumor-associated macrophages in HPV induced cervical cancer. Front Immunol 16:1586806","journal-title":"Front Immunol"},{"issue":"1","key":"11738_CR57","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e6","volume":"25","author":"N Jang","year":"2025","unstructured":"Jang N et al (2025) Regulation of ferroptosis in cancer and immune cells. Immune Netw 25(1):e6","journal-title":"Immune Netw"},{"issue":"1","key":"11738_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-025-05742-5","volume":"82","author":"R Zhou","year":"2025","unstructured":"Zhou R et al (2025) Sulfasalazine combined with anti-IL-1\u03b2 mAb induces ferroptosis and immune modulation in oral squamous cell carcinoma. Cell Mol Life Sci 82(1):1\u201316","journal-title":"Cell Mol Life Sci"},{"key":"11738_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1545928","volume":"16","author":"K Wang","year":"2025","unstructured":"Wang K et al (2025) The mechanism of action and therapeutic potential of tumor-associated macrophages in tumor immune evasion. Front Immunol 16:1545928","journal-title":"Front Immunol"},{"key":"11738_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149467","author":"M van der Merwe","year":"2025","unstructured":"van der Merwe M et al (2025) Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of progression, resistance, and emerging therapeutic strategies. Gene. https:\/\/doi.org\/10.1016\/j.gene.2025.149467","journal-title":"Gene"},{"issue":"1","key":"11738_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85329-z","volume":"15","author":"MH Ashoub","year":"2025","unstructured":"Ashoub MH et al (2025) siRNA-mediated inhibition of hTERT enhances the effects of curcumin in promoting cell death in precursor-B acute lymphoblastic leukemia cells: an in silico and in vitro study. Sci Rep 15(1):3083","journal-title":"Sci Rep"},{"issue":"1","key":"11738_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/imm.13860","volume":"174","author":"N Jawla","year":"2025","unstructured":"Jawla N et al (2025) Inherent metabolic preferences differentially regulate the sensitivity of Th1 and Th2 cells to ribosome\u2010inhibiting antibiotics. Immunology 174(1):73\u201391","journal-title":"Immunology"},{"key":"11738_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111191","author":"F Meng","year":"2025","unstructured":"Meng F et al (2025) Glucose metabolism impairment in major depressive disorder. Brain Res Bull. https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111191","journal-title":"Brain Res Bull"},{"issue":"1","key":"11738_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167565","volume":"1871","author":"X He","year":"2025","unstructured":"He X et al (2025) GPR68 supports AML cells through the calcium\/calcineurin pro-survival pathway and confers chemoresistance by mediating glucose metabolic symbiosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1871(1):167565","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"11738_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1545339","volume":"16","author":"D Sun","year":"2025","unstructured":"Sun D et al (2025) Lipid metabolism in ferroptosis: mechanistic insights and therapeutic potential. Front Immunol 16:1545339","journal-title":"Front Immunol"},{"issue":"2","key":"11738_CR66","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/1040841X.2024.2340643","volume":"51","author":"X Zhao","year":"2025","unstructured":"Zhao X, Zhang Y, Luo BJCrim (2025) Ferroptosis, from the virus point of view: opportunities and challenges. Crit Rev Microbiol 51(2):246\u2013263","journal-title":"Crit Rev Microbiol"},{"issue":"3","key":"11738_CR67","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/febs.16803","volume":"291","author":"X Li","year":"2024","unstructured":"Li X, Zhang HSJTFJ (2024) Amino acid metabolism, redox balance and epigenetic regulation in cancer. FEBS J 291(3):412\u2013429","journal-title":"FEBS J"},{"issue":"1","key":"11738_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01760-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X et al (2024) The significant role of amino acid metabolic reprogramming in cancer. Cell Commun Signal 22(1):380","journal-title":"Cell Commun Signal"},{"issue":"1","key":"11738_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12715-7","volume":"24","author":"S Fakhri","year":"2024","unstructured":"Fakhri S et al (2024) Phytochemicals regulate cancer metabolism through modulation of the AMPK\/PGC-1\u03b1 signaling pathway. BMC Cancer 24(1):1079","journal-title":"BMC Cancer"},{"issue":"1","key":"11738_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-024-01977-1","volume":"23","author":"S Yang","year":"2024","unstructured":"Yang S et al (2024) Crosstalk between metabolism and cell death in tumorigenesis. Mol Cancer 23(1):71","journal-title":"Mol Cancer"},{"key":"11738_CR71","doi-asserted-by":"crossref","unstructured":"Park S, Hall MNJE, Medicine M (2025) Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications. p. 1\u20139.","DOI":"10.1038\/s12276-025-01415-2"},{"issue":"1","key":"11738_CR72","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/imr.13274","volume":"321","author":"S Li","year":"2024","unstructured":"Li S et al (2024) Targeted therapy for non-small-cell lung cancer: new insights into regulated cell death combined with immunotherapy. Immunological Revi. 321(1):300\u2013334","journal-title":"Immunological Revi."},{"key":"11738_CR73","doi-asserted-by":"crossref","unstructured":"Caverzan MD, L.E.J.I.J.o.B.M Ibarra (2024) Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations. p. 134777.","DOI":"10.1016\/j.ijbiomac.2024.134777"},{"issue":"42","key":"11738_CR74","doi-asserted-by":"publisher","first-page":"28783","DOI":"10.1021\/jacs.4c07785","volume":"146","author":"J Wang","year":"2024","unstructured":"Wang J et al (2024) Blood-Brain Barrier-Penetrative Fluorescent Anticancer Agents Triggering Paraptosis and Ferroptosis for Glioblastoma Therapy. J the American Chemical Soc. 146(42):28783\u201328794","journal-title":"J the American Chemical Soc."},{"key":"11738_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107331","author":"W Ma","year":"2024","unstructured":"Ma W et al (2024) Ferroptosis inducers: a new frontier in cancer therapy. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107331","journal-title":"Bioorg Chem"},{"issue":"1","key":"11738_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-00920-2","volume":"19","author":"F Guo","year":"2024","unstructured":"Guo F et al (2024) Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK. Chinese Medicine 19(1):52","journal-title":"Chinese Medicine"},{"issue":"11","key":"11738_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04306-2","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y et al (2021) Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death Dis 12(11):1028","journal-title":"Cell Death Dis"},{"key":"11738_CR78","doi-asserted-by":"crossref","unstructured":"Scott KA, Njardarson JTJSC (2019) Analysis of US FDA-approved drugs containing sulfur atoms. p. 1\u201334.","DOI":"10.1007\/978-3-030-25598-5_1"},{"key":"11738_CR79","doi-asserted-by":"crossref","unstructured":"Steinbach JP, M.J.J.on-o (2004) Weller, Apoptosis in gliomas: molecular mechanisms and therapeutic implications. 70: p. 245\u2013254.","DOI":"10.1007\/s11060-004-2753-4"},{"issue":"24","key":"11738_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417633","volume":"24","author":"C Trejo-Solis","year":"2023","unstructured":"Trejo-Solis C et al (2023) Role of glycolytic and glutamine metabolism reprogramming on the proliferation, invasion, and apoptosis resistance through modulation of signaling pathways in glioblastoma. Int J Mol Sci 24(24):17633","journal-title":"Int J Mol Sci"},{"key":"11738_CR81","doi-asserted-by":"crossref","unstructured":"Eisele G, MJCl Weller (2013) Targeting apoptosis pathways in glioblastoma. 332(2): p. 335\u2013345.","DOI":"10.1016\/j.canlet.2010.12.012"},{"key":"11738_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-004-4205-6","volume":"73","author":"W-X Wang","year":"2005","unstructured":"Wang W-X, Ji Y-H-o (2005) Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro. J Neurooncol 73:1\u20137","journal-title":"J Neurooncol"},{"issue":"3","key":"11738_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030564","volume":"10","author":"K Gousias","year":"2022","unstructured":"Gousias K, Theocharous T, Simon MJB (2022) Mechanisms of cell cycle arrest and apoptosis in glioblastoma. Biomedicines 10(3):564","journal-title":"Biomedicines"},{"issue":"2","key":"11738_CR84","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ijrobp.2003.09.067","volume":"58","author":"C Belka","year":"2004","unstructured":"Belka C et al (2004) Apoptosis-modulating agents in combination with radiotherapy\u2014current status and outlook. Internat J Radiation Oncology Bio Phy 58(2):542\u2013554","journal-title":"Internat J Radiation Oncology Bio Phy"},{"key":"11738_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"FJ Li","year":"2022","unstructured":"Li FJ et al (2022) System X(c) (-)\/GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 13:910292","journal-title":"Front Pharmacol"},{"key":"11738_CR86","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","volume":"9","author":"X Sui","year":"2018","unstructured":"Sui X et al (2018) RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer. Front Pharmacol 9:1371","journal-title":"Front Pharmacol"},{"issue":"1","key":"11738_CR87","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","volume":"8","author":"Y Du","year":"2022","unstructured":"Du Y, Guo Z (2022) Recent progress in ferroptosis: inducers and inhibitors. Cell Death Discov 8(1):501","journal-title":"Cell Death Discov"},{"key":"11738_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana N, Ta KT, DelGiorno KE (2022) The role of Cystine\/Glutamate Antiporter SLC7A11\/xCT in the pathophysiology of cancer. Front Oncol 12:858462","journal-title":"Front Oncol"},{"issue":"3","key":"11738_CR89","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3892\/br.2017.948","volume":"7","author":"W Dong","year":"2017","unstructured":"Dong W et al (2017) NADPH oxidase inhibitor, diphenyleneiodonium prevents necroptosis in HK-2 cells. Biomed Rep 7(3):226\u2013230","journal-title":"Biomed Rep"},{"key":"11738_CR90","doi-asserted-by":"publisher","first-page":"e23198","DOI":"10.1002\/advs.202523198","volume":"3","author":"M Sabatier","year":"2026","unstructured":"Sabatier M et al (2026) GPX4 Inhibitor Resistance and Metastatic Features in Triple-Negative Breast Cancer. Advanced Sci 3:e23198","journal-title":"Advanced Sci"},{"key":"11738_CR91","first-page":"84","volume":"768","author":"R Beesoo","year":"2014","unstructured":"Beesoo R et al (2014) Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment. Mutat Res Fundam Mol Mech Mutagen 768:84\u201397","journal-title":"Mutat Res Fundam Mol Mech Mutagen"},{"issue":"3","key":"11738_CR92","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/152165400300001471","volume":"50","author":"S Hadi","year":"2000","unstructured":"Hadi S et al (2000) Putative mechanism for anticancer and apoptosis\u2010inducing properties of plant\u2010derived polyphenolic compounds. IUBMB Life 50(3):167\u2013171","journal-title":"IUBMB Life"},{"issue":"9","key":"11738_CR93","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/md9091580","volume":"9","author":"M Essack","year":"2011","unstructured":"Essack M, Bajic VB, Archer JAJMd (2011) Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment. Mar Drugs 9(9):1580\u20131606","journal-title":"Mar Drugs"},{"issue":"18","key":"11738_CR94","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1158\/0008-5472.CAN-06-0702","volume":"66","author":"E Aleo","year":"2006","unstructured":"Aleo E et al (2006) Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. Cancer Res 66(18):9235\u20139244","journal-title":"Cancer Res"},{"issue":"7","key":"11738_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/cells14070494","volume":"14","author":"J Tang","year":"2025","unstructured":"Tang J, Karbhari N, Campian JLJC (2025) Therapeutic targets in glioblastoma: Molecular pathways, emerging strategies, and future directions. Cells 14(7):494","journal-title":"Cells"},{"key":"11738_CR96","doi-asserted-by":"crossref","unstructured":"Kulavi S et al (2024) EIF4A3 targeted therapeutic intervention in glioblastoma multiforme using phytochemicals from Indian medicinal plants\u2013an integration of phytotherapy into precision onco-medicine. p 1\u201321.","DOI":"10.1080\/07391102.2024.2314257"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11738-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:02:45Z","timestamp":1774958565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11738-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11738"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11738-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"562"}}